期刊文献+

24h食管pH监测和食管测压及奥美拉唑治疗试验在食管原性胸痛中的应用

Utility of Ambulatory 24-hour Esophageal pH,Esophageal Manometry and Omeprazole Therapeutic Test in Esophageal Chest Pain
下载PDF
导出
摘要 目的 :探讨 2 4 h食管 p H监测和食管测压及奥美拉唑治疗试验在食管原性胸痛中的诊断价值。方法 :对食管原性胸痛 6 8例行内镜、食管测压、2 4 h食管 p H监测及 7d的奥美拉唑 (2 0 mg,2次 / d)治疗试验 ,治疗后症状评分比治疗前降低超过 75 %者则为治疗试验阳性。结果 :食管原性胸痛 6 8例中 5 5例 (81% )符合胃食管反流病 (GERD) ,胡桃夹食管 2例 ,早期贲门失驰缓症 3例 ,弥漫性食管痉挛 3例 ,无效食管运动 (IEM) 5例。GERD5 2例测压分析 ,35例(6 7% )符合 IEM诊断标准。奥美拉唑治疗试验对诊断 GERD的敏感性为 93% ,特异性为 85 %。结论 :GERD是食管原性胸痛的主要原因。 2 4 h食管 p H监测和食管测压是诊断食管原性胸痛的主要检查手段 ,奥美拉唑治疗试验是临床诊断GERD简便而实用的方法。 Objective:To assess the diagnostic value of ambulatory 24-hour esophageal pH, esophageal manometry and omeprazole therapeutic test in esophageal chest pain.Methods:Endoscopy,esophageal manometry and 24-hour esophageal pH monitoring were performed in 68 consecutive patients with esophageal chest pain. All subjects underwent a diagnostic test by receiving omeprazole 20mg twice daily for 7 days.A symptom reduction of over 75% after treatment was considered positive.Results:Of the 68 patients with esophageal chest pain, 55(81%) patients were diagnosed as gastroesophageal reflux disease (GERD),2 nutcracker esophagus, 3 Achalasia, 3 diffuse esophageal spasm, and 5 ineffective esophageal motility (IEM). 35 of the 52 (67%) patients with GERD met the diagnostic criteria for IEM. The sensitivity and specificity of omeprazole therapeutic test was 93% and 85% respectively.Conclusion:GERD is the primary finding in esophageal chest pain. Esophageal manometry and 24-hour esophageal pH monitoring are primary tools in the diagnosis of esophageal chest pain, and omeprazole therapeutic test is a simple and practical method in the diagnosis of GERD.
出处 《中国误诊学杂志》 CAS 2004年第2期184-186,共3页 Chinese Journal of Misdiagnostics
关键词 胸痛/病因学 食管活动障碍/治疗 胃食管反流/诊断 氢离子浓度 奥美拉唑/治疗应用 Chest pain/etiology Esophageal motility disorders/diagnosis Gastroesophageal reflux/diagnosis Hydrogen-Ion concentration Omeprazole/therapeutic use.
  • 相关文献

参考文献10

  • 1Pandak WM, Arezo S, Everett S,et al.Short course of omeprazole:a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.J Clin Gastroenterol,2002,35(4):307-314.
  • 2Spechler SJ, Castell DO.Classification of oesophageal motility abnormalities. Gut,2001,49(1):145-151.
  • 3Shrestha S, Pasricha PJ. Update on noncardiac chest pain. Dig Dis, 2000,18(3): 138-146.
  • 4Wingate D, Hongo M, Kellow J,et al.Working party report. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol, 2002,17(Suppl):1-14.
  • 5Jaup BH. Effective and inhibition as a diagnostic tool for gastroesophageal reflux disease.Gut,1995,37(Suppl 2):36.
  • 6Durazzo M, Premoli A, Pellicano R, Oliaro A. The esophageal chest pain. An update for clinicians. Panminerva Med, 2002,44(1):61-67.
  • 7Richter JE, Bradley LA, and Castell DO. Esophageal chest pain: Current controversies in pathogenesis, diagnosis and therapy. Ann Intern Med, 1989,110(1):66.
  • 8Botoman VA. Noncardiac chest pain. J Clin Gastroenterol, 2002, 34(1):6-14.
  • 9Lam HGTH, Dekker W, Kan G, et al. Acute noncardiac chest pain in acoronary care unit: evaluation by 24-hour pressure and recording of the esophagus. Gastroenterology,1992,102(2): 453-458.
  • 10Szarka LA,DeVault KR, Murray JA.Diagnosing gastroesophageal reflux disease. Mayo Clin Proc,2001,76(1):97-101.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部